Skip to main content
. 2022 Nov 25;15(1):e16033. doi: 10.15252/emmm.202216033

Figure EV5. LNPs‐miR‐182‐3p treatment does not compromise tissue viability in proliferative and non‐proliferative organs.

Figure EV5

Proliferative (Intestine, Skin, Bone marrow, Spleen) and non‐proliferative (Brain, Heart, Liver, Kidney, Lung) organs taken from mice, previously treated with LNPs‐empty or LNPs‐miR‐182‐3p, were assayed by hematoxylin and eosin (H&E) staining. Sections from two different mice are shown. Scale bar: 200 μm.